Metraipolis › archive › dc_a7d5df5ebca5

Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review — Europe PMC PMID:41303533

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41303533
DOI
10.3390/ijms262211049
License (as archived)
solo-consultazione
Archived
2026-11-08T13:09:07.809Z
SHA-256 of the archived text
b1371edc14f26f9e6d78fdf0286a427d5029b5e363e2c62957302d4bdf8eeb4f
Stable URL of this page
https://metraipolis.com/documento/dc_a7d5df5ebca5

How to cite

Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review — Europe PMC PMID:41303533 — Europe PMC (en), https://europepmc.org/article/MED/41303533 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a7d5df5ebca5 (Metraipolis archive dc_a7d5df5ebca5, sha256 b1371edc14f26f9e6d78fdf0286a427d5029b5e363e2c62957302d4bdf8eeb4f)
BibTeX
@misc{dca7d5df5ebca5,
  title = {Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review — Europe PMC PMID:41303533},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41303533},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a7d5df5ebca5; sha256 b1371edc14f26f9e6d78fdf0286a427d5029b5e363e2c62957302d4bdf8eeb4f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303533. Agents can read the archived copy with the MCP tool read_document.